Home › Core › ISCC-IDs › 28C6QCRk6LnKF

View ISCC-ID

Core Data

28C6QCRk6LnKF
ISCC-ID - digital asset identifier
CCGDpf4ffZvJA-CTvmXQt7ewNvS-CDXQVU1ehbykQ-CR5CNHChLv5mY
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

modelbased metaanalysis to evaluate optimal doses of direct oral factor xa inhibitors in atrial fibrillation patients

Ledger Reference

coblo
Source Ledger/Blockchain
12408192
N-th ISCC Decleration on source ledger
26c99671c1ad2179e92c20e76477316b644d0b6f2b1a86e2423208636acf6789
Hash of block that includes the ISCC-DECLARATION
9f4a70016e6f82fa9922815d1cb772d97daddaf6ac9ba9dbf5a395595e01e9e5
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Hideki Yoshioka", "@type": "Person"}, {"name": "Hiromi Sato", "@type": "Person"}, {"name": "Hiroto Hatakeyama", "@type": "Person"}, {"name": "Akihiro Hisaka", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc5965044?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Society of Hematology", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1182/bloodadvances.2017013805", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCGDpf4ffZvJA-CTvmXQt7ewNvS-CDXQVU1ehbykQ-CR5CNHChLv5mY", "propertyID": "ISCC"}], "datePublished": "2018-05-14"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close